Insurer to pay 22.5 million in settlement
Insurer to pay $22.5 million in settlement for allegedly defrauding Medicare with inflated diagnostic codes for medicare advantage plans.
Featured Stories
All Stories →Governors seek delay in Medicaid work rules
Governors seek delay in Medicaid work rules due to recent guidance changes from Centers for Medicare & Medicaid Services.
Insurers Cut Medicare Advantage Benefits Despite Promises
Medicare Advantage benefits are being reduced as insurers cut dental coverage and Part B premium refunds despite 2027 promises, per…
Essentia and HealthPartners plan merger amid Minnesota hospital deals
Essentia and HealthPartners plan a merger to form a major health system operating 22 hospitals and 45,000 employees across Minnesota…
Drug Monitoring
More →
Governors seek delay in Medicaid work rules
Insurers Cut Medicare Advantage Benefits Despite Promises
MedPAC Chair Defends MA Overpayment Estimate
Mindset shift needed for sustainable weight loss
Nutrition Desk
More →
AI Billing Tools Spark Healthcare Cost Debate
Couple defies age with a lifetime of mountain adventures
Wellness Rituals for Men After Gym and Shower
Condition Spotlight
More →
Essentia and HealthPartners plan merger amid Minnesota hospital deals
Walking patterns linked to joint and back pain
Enclomiphene Therapy Adjusted for Men with Anxiety, Depression History
Biomarkers Unveil Hidden Health Insights
Preventive Care
More →
Insurer to pay 22.5 million in settlement
UnitedHealthcare appoints new president
Simple Habits Promote Good Oral Health
Firebrands by Vicky Oliver reviewed
Lifestyle Medicine
More →
Hospitals in 340B program spend less on charity
AI to Inflate Healthcare Costs, Oz Warns
Aloe Vera Has Limited Vaginal Health Benefits
New fitness guide for tactical athletes released
Popular Posts
Refresh ↺Bharat Bhise Looks at The Validity of The Growing Demand for Health Supplements
Introduction According to Bharat Bhise, the global health supplements market has an estimated value of $155 billion in 2022 and…
Weight loss surgery demand drops as drugs rise
Weight loss surgery demand drops as GLP-1 drugs rise, cutting bariatric procedure rates by 8.7% amid soaring prescriptions.
Why Asia-Pacific Hospitals Lag on Outcome-Based Care
Why Asia-Pacific hospitals lag on outcome-based care despite rising interest. Explore data gaps and treatment standards in Bain & Company's…
PET scans predict arthritis treatment success
PET scans help predict arthritis treatment success and reduce permanent damage to joints with early detection and management of rheumatoid…
Large study sheds light on pregnancy liver disease
A large international study on pregnancy liver disease reveals how ICP disrupts bile acid, fat, and cholesterol metabolism, offering new…
AI Billing Tools Spark Healthcare Cost Debate
Insurers claim AI could significantly increase healthcare costs, sparking a debate over the financial impact of AI-driven billing tools and…
